BERG CHARLES
Known title: DirectorCIK: 0001111804
Associated companies
Transaction History
| DVA | ▲ Buy | Grant | 348 | $0 | 5/15/2025 | View on chart |
| DVA | ▲ Buy | Grant | 349 | $0 | 3/15/2025 | View on chart |
| DVA | ▲ Buy | Grant | 312 | $0 | 11/15/2024 | View on chart |
| DVA | ▲ Buy | Grant | 333 | $0 | 8/15/2024 | View on chart |
| DVA | ▲ Buy | Grant | 363 | $0 | 5/15/2024 | View on chart |
| DVA | ▲ Buy | Grant | 366 | $0 | 3/15/2024 | View on chart |
| DVA | ▲ Buy | Grant | 529 | $0 | 11/15/2023 | View on chart |
| DVA | ▲ Buy | Grant | 475 | $0 | 8/15/2023 | View on chart |
| DVA | ▲ Buy | Grant | 516 | $0 | 5/15/2023 | View on chart |
| DVA | ▲ Buy | Grant | 658 | $0 | 3/15/2023 | View on chart |
| DVA | ▼ Sell | Open Market | 1,431 | $108K | 3/9/2023 | View on chart |
| DVA | ▼ Sell | Open Market | 735 | $60K | 3/1/2023 | View on chart |
| DVA | ▲ Buy | Option Exercise | 7,165 | $475K | 2/28/2023 | View on chart |
| DVA | ▼ Sell | Other | 5,734 | $475K | 2/28/2023 | View on chart |
| DVA | ▲ Buy | Option Exercise | 3,601 | $237K | 2/24/2023 | View on chart |
| DVA | ▼ Sell | Other | 2,866 | $238K | 2/24/2023 | View on chart |
| DVA | ▲ Buy | Grant | 677 | $0 | 11/15/2022 | View on chart |
| DVA | ▲ Buy | Grant | 514 | $0 | 8/15/2022 | View on chart |
| DVA | ▲ Buy | Grant | 475 | $0 | 5/15/2022 | View on chart |
| DVA | ▲ Buy | Grant | 429 | $0 | 3/15/2022 | View on chart |
| DVA | ▲ Buy | Grant | 446 | $0 | 11/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
DaVita (DVA) Discussed as Potentially Undervalued Cash Producer
Recent articles highlight DaVita as a cash-producing stock that may be undervalued relative to its earnings power. The company has outperformed the broader market recently, with one analysis noting a 58% gain. While the stock is trading near its 52-week low, analysts maintain a higher average price target, suggesting a gap between current price and long-term expectations.
DaVita (DVA) Discussed as Potentially Undervalued Cash Producer. Recent articles highlight DaVita as a cash-producing stock that may be undervalued relative to its earnings power. The company has outperformed the broader market recently, with one analysis noting a 58% gain. While the stock is trading near its 52-week low, analysts maintain a higher average price target, suggesting a gap between current price and long-term expectations.